COMP <GO>
CVSA vs LRN // EV/EBITDA & P/E VALUATION
Covista Inc. (NYSE) VS. Stride Inc. (NYSE) • 15-METRIC TALLY: CVSA 5
— LRN 8
▲ EV/EBITDA & P/E VALUATION LEADER: LRN
LAST: $124.33 (-3.44%) • MKT CAP: $4.36B
valuation
12.5x
LAST: $78.36 (-2.90%) • MKT CAP: $3.39B
valuation
9.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVSA VS. LRN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVSA | LRN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.90% | 39.20% | +17.70 | CVSA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.80% | 19.40% | -4.60 | LRN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.5x | 9.2x | +3.30 | LRN | /valuation <GO> |
| Free Cash Flow Yield | 6.60% | 12.70% | -6.10 | LRN | /fcf-yield <GO> |
| Operating Margin | 19.10% | 15.00% | +4.10 | CVSA | /operating-margins <GO> |
| Net Profit Margin | 13.30% | 12.00% | +1.30 | CVSA | /net-margins <GO> |
| Revenue Growth (YoY) | 12.90% | 17.90% | -5.00 | LRN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 3.40% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.73 | 5.58 | -0.85 | LRN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | LRN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 50.8 | +1.10 | CVSA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.08 | -0.03 | LRN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.5x | 9.9x | +5.60 | LRN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.36B | $3.39B | $966.5M | CVSA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVSA REV | LRN REV | CVSA GROSS % | LRN GROSS % | CVSA FCF | LRN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.79B | $2.41B | 56.9% | 39.2% | $287.6M | $431.0M |
| FY 2024 | $1.58B | $2.04B | 55.9% | 37.4% | $246.9M | $276.5M |
| FY 2023 | $1.45B | $1.84B | — | — | $126.6M | $120.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVSA // BETA 1.05
LRN // BETA 1.08